Symptomatic relief is related to serum free triiodothyronine concentrations during follow-up in levothyroxine-treated patients with differentiated thyroid cancer - Larisch, R; Midgley, JEM; Dietrich, JW (Exp Clin Endocrinol Diabetes, 2018)
et al.